We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NODK:NASDAQNI Holdings, Inc. Analysis

Data as of 2026-06-17 - not real-time

$15.57

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

NI Holdings is trading at $15.57, notably below its DCF‑derived fair value of $20.71, indicating a potential upside of roughly 30%. Technical signals are mixed: the 20‑day SMA ($14.60) sits above the 50‑day ($13.71) and 200‑day ($13.47) averages, supporting a bullish bias, while the MACD line remains above its signal line, yet the RSI is perched at 80, flagging an overbought condition. Volume trends are weakening, with recent activity lower than the 10‑day average, suggesting reduced buying pressure as the price approaches the resistance level of $15.98. On the fundamentals side, the company posted a 16.6% decline in revenue and negative gross and profit margins, with a trailing EPS of –$0.21, but it generated positive free cash flow of $27.86 M and maintains a low beta of 0.36, dampening market‑wide volatility exposure. Overall, the stock appears undervalued yet financially fragile, with upside potential tempered by earnings weakness and high short‑term technical risk.
Given the disparity between valuation upside and deteriorating earnings, investors should weigh the attractive price against the company’s operational challenges. The low beta and modest volatility (21% over 30 days) mitigate some risk, but the decreasing liquidity and sector‑specific regulatory pressures keep the risk profile moderate. A cautious stance—holding for potential price correction while monitoring cash‑flow trends—aligns with the current data landscape.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • RSI above 80 indicating overbought conditions
  • Price near resistance at $15.98
  • Decreasing volume trend reducing short‑term momentum

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Bullish SMA alignment (20‑day > 50‑day > 200‑day)
  • DCF fair value suggests ~30% upside
  • Low beta (0.36) limiting market volatility exposure

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap between market price and fair value
  • Positive free cash flow despite earnings loss
  • Stable sector fundamentals and limited geographic concentration

Key Metrics & Analysis

Financial Health

Revenue Growth-16.60%
Profit Margin-1.60%
ROE-1.73%
ROA-0.54%
Debt/Equity0.51
P/B Ratio1.3
Op. Cash Flow$-27027000
Free Cash Flow$27.9M
Industry P/E17.1

Technical Analysis

TrendBullish
RSI80.2
Support$13.56
Resistance$15.98
MA 20$14.60
MA 50$13.71
MA 200$13.47
MACDBullish
VolumeDecreasing
Fear & Greed Index92.13

Valuation

Fair Value$20.71
GradeUndervalued
TypeValue

Risk Assessment

Beta0.37
Volatility21.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.